Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma

Michael Kent, David Rice, Raja Flores

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The clinical presentation of malignant pleural mesothelioma (MPM) is nonspecific. The process to obtain the correct diagnosis can be challenging and requires a high index of suspicion. Once the diagnosis is made, there is no universally accepted standard of care and treatment decisions are strongly influenced by physician bias. Physicians who see few numbers of patients tend to treat based on symptoms alone by drainage of the pleural effusion and talc pleurodesis, while physicians at several tertiary referral centers tend to take an aggressive multimodality approach incorporating surgical resection, chemotherapy, and radiation. The primary goal of surgery in this setting is the resection of all gross disease. The choice of operation, extrapleural pneumonectomy (EPP) or pleurectomy/decortication (P/D), depends on disease stage, pulmonary function, philosophy of the treating physician, and type of planned adjuvant therapy.

Original languageEnglish (US)
Pages (from-to)158-170
Number of pages13
JournalCurrent treatment options in oncology
Volume9
Issue number2-3
DOIs
StatePublished - 2008

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma'. Together they form a unique fingerprint.

Cite this